Label-Free, High Content Screening Using Raman Microspectroscopy: The Toxicological Response of Different Cell Lines to Amine-Modified Polystyrene Nanoparticles by Efeoglu, Esen et al.
Technological University Dublin 
ARROW@TU Dublin 
Articles NanoLab 
2017 
Label-Free, High Content Screening Using Raman 
Microspectroscopy: The Toxicological Response of Different Cell 
Lines to Amine-Modified Polystyrene Nanoparticles 
Esen Efeoglu 
Technological University Dublin, esen.efeoglu@tudublin.ie 
Alan Casey 
Technological University Dublin, alan.casey@tudublin.ie 
Hugh J. Byrne 
Technological University Dublin, hugh.byrne@tudublin.ie 
Marcus A. Maher 
Technological University Dublin, Marcus.Maher@mydit.ie 
Follow this and additional works at: https://arrow.tudublin.ie/nanolart 
 Part of the Medicine and Health Sciences Commons 
Recommended Citation 
Efeoglu, E., Casey, A. & Maher, M. (2017). Label-free, high content screening using Raman 
microspectroscopy: the toxicological response of different cell lines to amine-modified polystyrene 
nanoparticles. The Analyst, August 2017. doi:10.1039/c7an00461c 
This Article is brought to you for free and open access by 
the NanoLab at ARROW@TU Dublin. It has been accepted 
for inclusion in Articles by an authorized administrator of 
ARROW@TU Dublin. For more information, please 
contact yvonne.desmond@tudublin.ie, 
arrow.admin@tudublin.ie, brian.widdis@tudublin.ie. 
This work is licensed under a Creative Commons 
Attribution-Noncommercial-Share Alike 3.0 License 
Analyst
PAPER
Cite this: DOI: 10.1039/c7an00461c
Received 16th March 2017,
Accepted 4th August 2017
DOI: 10.1039/c7an00461c
rsc.li/analyst
Label-free, high content screening using Raman
microspectroscopy: the toxicological response of
different cell lines to amine-modified polystyrene
nanoparticles (PS-NH2)†
Esen Efeoglu, *a,b Marcus A. Maher, b Alan Casey b and Hugh J. Byrne b
Nanotoxicology has become an established area of science due to growing concerns over the production
and potential use of nanomaterials in a wide-range of areas from pharmaceutics to nanomedicine.
Although different cytotoxicity assays have been developed and are widely used to determine the toxicity
of nanomaterials, the production of multi-parametric information in a rapid and non-invasive way is still
challenging, when the amount and diversity of physicochemical properties of nanomaterials are
considered. High content screening can provide such analysis, but is often prohibitive in terms of capital
and recurrent costs in academic environments. As a label-free technique, the applicability of Raman
microspectroscopy for the analysis of cells, tissues and bodily fluids has been extensively demonstrated.
The multi-parametric information in the fingerprint region has also been used for the determination of
nanoparticle localisation and toxicity. In this study, the applicability of Raman microspectroscopy as a
‘high content nanotoxicological screening technique’ is demonstrated, with the aid of multivariate
analysis, on non-cancerous (immortalized human bronchial epithelium) and cancerous cell-lines (human
lung carcinoma and human lung epidermoid cells). Aminated polystyrene nanoparticles are chosen as
model nanoparticles due to their well-established toxic properties and cells were exposed to the
nanoparticles for periods from 24–72 hours. Spectral markers of cellular responses such as oxidative
stress, cytoplasmic RNA aberrations and liposomal rupture are identified and cell-line dependent systema-
tic variations in these spectral markers, as a function of the exposure time, are observed using Raman
microspectroscopy, and are correlated with cellular assays and imaging techniques.
Introduction
The ease of interaction of nanomaterials with biological mole-
cules and living systems can be utilized to design novel nano-
particles for gene and drug delivery, personalised medicine,
diagnosis as well as imaging technologies.1–4 Conversely, the
physicochemical properties which give rise to this interaction
and the high reactivity with biological systems can make them
potentially toxic to humans.5,6 When the amount and physico-
chemical diversity of naturally occurring and manufactured
nanomaterials are considered, determination of toxic pro-
perties, possible adverse health effects and mechanism of
action in a rapid, in vitro and multi-parametric fashion with a
single assay carries significant importance to take full advan-
tage from nanomaterials in a wide range of application areas.
Various biological assays and imaging technologies have been
introduced for the determination of cell–nanoparticle inter-
actions, monitoring of nanoparticle uptake and localisation.
The commercially available and well established cytotoxicity
assays, Alamar Blue (AB), 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) and neutral red (NR), are
nanotoxicological assessments recommended by the
Organisation for Economic Co-operation and Development
(OECD) for the determination of the nanoparticle toxicity.7
However, the established techniques have remained limited
due to the time needed for each experiment, requirement of
multiple-labels and/or their invasive nature.
Over the last decade, High Content Analysis/Screening
(HCA/HCS), which can be described as automated imaging
and analysis of ‘phenotypic assay endpoints’ for the evaluation of
multiple information sources regarding cell morphology, bio-
chemical parameters in cells, tissue-level toxicity, as well as
animal disease models, has brought a new perspective to, for
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example, drug discovery and academic research.8–10 HCA has
been used to replace cellular assays for cell signalling,9,11,12
neurobiology,13,14 in vitro toxicology,10,15,16 cell physiology17,18
and many other applications due to its speed, sensitivity and
multifaceted data which provide advantages over conventional
cellular assays. However, this technology still remains challenging
because of the cost, problems in data management, development
of application based models and lack of common standards.8
The applicability of Raman microspectroscopy to the inves-
tigation of biological systems has been demonstrated pre-
viously for tissues, cells, body fluids and also drug and nano-
particle screening.19–26 The power of the Raman microspectro-
scopy to differentiate cellular regions such as nucleus, nucleo-
lus and cytoplasm along with the localisation of nanoparticles
has been shown by Dorney et al.26 The localisation of the car-
boxyl modified-polystyrene nanoparticles (PS-COOH) at certain
time points has been also demonstrated using Raman micro-
spectroscopy and spectral biomarkers corresponding to cellu-
lar compartments such as endosomes, lysosomes and endo-
plasmic reticulum have been identified.22 The correlation of
Raman signatures with cytotoxicity assays for carbon nano-
tubes was demonstrated by Knief et al.27 The importance of
the combination of multivariate analysis techniques to extract
information from Raman data sets regarding nanoparticle
localisation in cellular regions has been demonstrated by
Keating et al.28 The ability of Raman microspectroscopy to
determine spectral markers of the dose and time dependent
cellular responses and the corresponding changes in bio-
chemical constituents of the cells upon exposure to aminated
polystyrene (PS-NH2) nanoparticles has been also studied.
21
Hereby, this study focuses on validation of the technique of
Raman microspectroscopy as a label free, ‘high content nano-
toxicological screening’ method in cancerous and non-cancer-
ous cell lines based on spectral markers of cellular responses
triggered by nanoparticle uptake. For this purpose, a non-can-
cerous, immortalized human bronchial epithelium cell line
(BEAS-2B), and cancerous cell lines, human lung carcinoma
(A549) and human lung epidermoid (Calu-1), are used, as they
act as models for human exposure by inhalation. Aminated
polystyrene nanoparticles (PS-NH2) were chosen as model
nanoparticles due to their extensively-studied toxic
properties.15,29–33 The toxic forms of the polystyrene nano-
particles (PS), e.g. PS-NH2, have previously been demonstrated
to result in ROS formation and oxidative stress upon exposure
which triggers apoptosis by the release of inflammatory
factors.15,31,32,34 In this study, the effects of the PS-NH2 on the
cancerous and non-cancerous cell lines were evaluated by
using the commercially available and well-established toxicity
assays AB and MTT from 24 to 72 h for each cell line. Raman
microspectroscopic studies were carried out at sublethal doses
in order to observe the progressive evolution of the spectro-
scopic signatures of the toxicity in the fingerprint region for
BEAS-2B, A549 and Calu-1 cells. Cells were exposed to PS-NH2
from 24 to 72 h and corresponding controls for each cell line
were prepared for comparison with the exposed cells. Raman
spectra were acquired from the cytoplasm of the exposed and
control cells and unsupervised principal component analysis
(PCA) was used to evaluate changes upon PS-NH2 exposure.
Predicted toxic events based on Raman microspectroscopy
such as oxidative stress and lysosomal damage were deter-
mined by using the 6-carboxy-2′,7′-dichlorodihydrofluorescein
diacetate (carboxy-H2DCFDA) dye and lysosensor, respectively
and results were correlated with the Raman spectral markers.
Materials and methods
Nanoparticles and preparation of PS-NH2 solutions
Commercially available, 100 nm amine-modified and fluores-
cently labelled polystyrene nanoparticles (PS-NH2) were pur-
chased from Sigma-Aldrich (L9904) and used throughout the
study. The calculation of the stock concentration was made by
using the manufacturer’s instructions. Excitation and emis-
sion spectra are supplied by Sigma-Aldrich and have maxima
at 481/644 nm, respectively.
PS-NH2 working solutions were prepared by dispersing
nanoparticles directly into the pre-heated (37 °C), 10% foetal
bovine serum (FBS) and 2 mM L-glutamine supplemented in
Dulbecco’s Modified Eagle’s Medium Nutrient Mixture F-12
HAM (DMEM-F12) or Roswell Park Memorial Institute
(RPMI-1640) Medium, depending on the cell line. Initial stock
concentration was calculated as 2.05 mM and working concen-
trations were freshly prepared prior to exposure. More infor-
mation about working solutions and concentrations is sup-
plied in the relevant sections of the following.
Reagents
For cytotoxicity evaluation of 100 nm PS-NH2, 3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and
Alamar Blue (AB) assays were purchased from Sigma Aldrich
Ltd (Dublin, Ireland) and Biosource (UK), respectively. For the
determination of reactive oxygen species (ROS), 6-carboxy-2′,7′-
dichlorodihydrofluorescein diacetate (carboxy-H2DCFDA) was
purchased from Invitrogen (Ireland). In order to observe
lysosomal activity and aberrations in intracellular pH,
Lysosensor™ green DND-189 (L7535) was purchased from Life
Technologies, Ireland.
Cell culture
Toxicological effects of 100 nm PS-NH2 on cancerous and non-
cancerous cell lines were evaluated. BEAS-2B (ATCC®
CRL-9609™), a normal immortalized human bronchial epi-
thelium cell line, was used as a model non-cancerous cell line,
whereas A549 (ATCC number CCL-185™), human lung carci-
noma, and Calu-1 (ECACC 93120818), human lung epidermoid
cells, were chosen as model cancerous cell lines. BEAS-2B and
A549 cell lines were purchased from American Type Culture
Collection (ATTC) and Calu-1 cells were obtained from the
European Collection of Authenticated Cell Cultures (ECACC).
A549 and BEAS-2B cells were cultured in (DMEM-F12) with
2 mM L-glutamine and 10% foetal bovine serum (FBS) at 37 °C
in 5% CO2. For Calu-1 cells, the growth conditions were the
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same as for A549 and BEAS-2B, with the exception that the
culture medium used was RPMI-1640, with 10% FBS and
2 mM L-glutamine supplement. A549 and Calu-1 cells were
sub-cultured every 3 days, the BEAS-2B cell line every 4 days,
until cells reached approximately 60–70% confluency.
AB (Alamar Blue) and MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) assays and calculation of half-
maximal effective concentration EC50 values
Both assays for the evaluation of cytotoxicity of the 100 nm
PS-NH2 to the chosen cell lines were conducted in the same
plate. For cytotoxicity evaluation, each cell line was seeded
onto 96-well plates at densities of 1 × 105, 5 × 104 and 3 × 104
cells per mL for 24, 48 and 72 hours, respectively. The cells
were incubated at 37 °C in a 5% CO2 humidified incubator for
24 h to achieve the initial attachment and desired confluency.
For each cell line, six replicates of the positive (10% dimethyl
sulfoxide (DMSO)) and negative (cell lines) control and particle
exposures were used and 3 independent experiments were
carried out from the same batch of the cells after different
passages to evaluate toxicity.
PS-NH2 solutions within the concentration range of 20 μM
to 0.15 μM were freshly prepared in pre-heated cell medium
with 10% FBS and 2 μM L-glutamine. For A549 and BEAS-2B
cell lines, particles were prepared in DMEM-F12, whereas
RPMI medium with 10% FBS and 2 μM L-glutamine was used
for particle exposure to the Calu-1 cells.
Following 24 h initial attachment, the cells were rinsed with
100 μL per well of pre-warmed PBS and exposed to the test
materials for 24, 48 and 72 h. After the desired exposure time,
the cells were washed with PBS twice and exposed to the AB/
MTT solution prepared in un-supplemented medium (A549
and BEAS-2B; DMEM-F12, Calu-1; RPMI) in the ratio of 5%
[v/v] of AB and 10% [v/v] of MTT. Then the cells were incubated
with the AB/MTT solution at 37 °C in 5% CO2 for 3 h. A micro-
plate reader (SpectraMax-M3, Molecular Devices, USA) was
used to measure AB fluorescence emission at 595 nm.
Following AB measurements, the AB/MTT solution was
removed and the cells were washed with 100 μL per well of PBS
twice. 100 μL per well of DMSO were added to 96-well plates
and the plates were agitated at 200 rpm for 10 min. MTT absor-
bance was measured using the micro-plate reader at 570 nm.
Data were transferred to SigmaPlot to fit the EC50 curve by
using a four parameter sigmoidal fit.
Confocal laser scanning fluorescence microscopy
Confocal laser scanning microscopy (CLSM) was used to deter-
mine nanoparticle uptake and to observe cellular changes
upon nanoparticle exposure as well as morphological changes
in control cells over the exposure time. For each cell line, 1 ×
105 cells per substrate were seeded onto glass bottom Petri
dishes in the respective medium and incubated for 24 h at
37 °C in 5% CO2. Following 24 h initial growth, cell medium
was changed for the control cells and the test samples were
exposed to 2.5, 1 and 0.6 μM of PS-NH2 (calculated EC25
values) for A549, Calu-I and BEAS-2B, respectively and the cells
were incubated for 24, 48 and 72 h. After the desired exposure
time, the cells were rinsed with PBS three times and kept in
PBS for confocal studies. CLSM images were taken by using a
Zeiss Confocal Fluorescence Microscope (LSM 510 META, Carl
Zeiss, Germany) with a ×63 oil immersion objective.
Raman microspectroscopy
In this study, Raman microspectroscopy is used to monitor cel-
lular responses upon 100 nm PS-NH2 exposure in cancerous
(A549, Calu-1) and non-cancerous (BEAS-2B) cell lines to
compare spectral fingerprints of molecular initiating events as
well as cell death signatures. Cells were seeded onto CaF2 discs
at a density of approximately 16 000 cells per substrate and
incubated for 24 h at 37 °C in 5% CO2 in the respective
medium for the cell line. Following initial attachment and
growth, the cell medium was removed and the cells were
rinsed with pre-warmed PBS. The cells were exposed to 2.5,
1 and 0.6 μM of 100 nm PS-NH2 in cell medium supplemented
with 10% FBS and 2 μM L-glutamine for A549, Calu-1 and
BEAS-2B, respectively. The cells were incubated at 37 °C in 5%
CO2 for periods of 24, 48 and 72 h. For the control cells, the
cell medium was replaced by fresh pre-warmed medium for a
period equivalent to the PS-NH2 exposure times. Following
exposure, cell medium was removed and the cells were washed
with 2 mL of PBS three times. 10% formalin was used as a fixa-
tive reagent and incubated with cells at room temperature for
10 min. After fixation, the cells were washed with PBS twice
and kept in sterile dH2O for Raman studies.
Throughout the study, a Horiba Jobin-Yvon LabRAM HR800
spectrometer, equipped with a 785 nm diode laser as a source,
was used with a ×100 immersion objective (LUMPlanF1,
Olympus, N.A. 1). The 520.7 cm−1 line of silicon was used to
calibrate the spectrometer prior to spectral acquisition. A 300
lines per mm grating and a 100 μm confocal pinhole were
chosen for all measurements and spectra were collected by
using a 16 bit dynamic range Peltier cooled CCD detector. 20
point spectra from the cytoplasm of A549, Calu-1 and BEAS-2B
cells and the corresponding controls for each exposure time
were acquired for 2 × 30 seconds at each spot in the fingerprint
region (from 400 cm−1 to 1800 cm−1). Control cells incubated
in the respective medium for up to 72 h were used to deter-
mine spectral changes as a result of particle exposure in
PS-NH2 exposed cells.
Data analysis
In order to observe the signatures of biochemical changes in
cells upon PS-NH2 exposure, the Raman data sets obtained
from the exposed cells and their controls for different exposure
times were transferred to Matlab (Mathworks, USA) for data
analysis. All data sets were subjected to pre-processing prior to
multivariate analysis. Briefly, a mild smoothing (Savitzky–Golay
filter, 3rd order, 9 points) was applied and background was
removed by using Classical Least Squares Analysis (CLSA) to
remove contributions from the water in the immersion geome-
try.24,35 Smoothed and background removed spectra were vector
normalised prior to principal components analysis (PCA).
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Intracellular reactive oxygen species (ROS) study
Generation of oxidative oxygen species in A549, Calu-1 and
BEAS-2B cell lines for selected concentrations was evaluated by
using the carboxy-H2DCFDA dye. Cells were seeded onto
96-well plates at a density of 1 × 105 cells per well and incu-
bated at 37 °C in 5% CO2 for 24 h for initial attachment and
growth. Following initial attachment, the cells were rinsed
with 100 μL per well of PBS and 100 μL per well of carboxy-
H2DCFDA dye, prepared in PBS at a concentration of 10 μM,
were added into the 96-well plates and the cells were incubated
at 37 °C in 5% CO2 for 30 min. After 30 min, the dye solution
was removed from the plates and the cells were rinsed with
100 μL per well PBS twice. The cells were exposed to 0.6, 1 and
2.5 μM of PS-NH2 prepared in pre-warmed cell medium with
10% FBS and 2 μM L-glutamine for BEAS-2B, Calu-1 and A549
cell lines, respectively. A 100 μM hydrogen peroxide (H2O2)
solution was used as a positive control for all cell lines. The
cells were incubated with test materials for 1, 2, 3, 4, 6 and
24 h. For positive and negative controls and PS-NH2 exposure,
6 replicates are used in the same 96-well plate and 3 indepen-
dent experiments were carried out from the same batch of the
cells after different passages to evaluate the generation of reac-
tive oxygen species (ROS). The plates were kept away from light
throughout the experiment. The fluorescence emission of the
oxidized DCFDA dye (excitation/emission: 485/535 nm) was
measured at 535 nm by using a micro-plate reader
(SpectraMax-M3, Molecular Devices, USA).
Lysosensor study
Lysosensor Green DND-189 was used to monitor lysosomal
activity and aberrations in lysosomal activity for A549, Calu-1
and BEAS-2B upon exposure to 2.5, 1 and 0.6 μM concen-
trations of PS-NH2. 10% DMSO was used as a positive control
for all cell lines. Cells were seeded onto 96-well plates at a
density of 1 × 105 cells per mL in pre-warmed medium sup-
plemented with 10% FBS and 2 μM L-glutamine and incubated
for 24 h at 37 °C in 5% CO2. Following 24 h initial attachment,
the cells are washed with PBS and exposed to test materials
prepared in the respective medium for periods of 1, 2, 3, 4, 6
and 24 h. Lysosensor was prepared at a concentration of 2 μM
in pre-warmed PBS. After the desired exposure time, the cells
were washed twice with pre-warmed PBS and the cells were
exposed to dye solutions for 30 min. After 30 min, plates were
rinsed with PBS twice to remove unloaded dye and cells were
kept in 100 μL per well PBS for the measurements. Lysosensor
fluorescence emission was measured by using a micro-plate
reader (SpectraMax-M3, Molecular Devices, USA) at 535 nm
(Ex/Em: 488/535 nm).
Results and discussion
The cytotoxic effect of PS-NH2 on cancerous and non-cancer-
ous cell lines
The effect of 100 nm PS-NH2 on cancerous (A549, Calu-1) and
non-cancerous (BEAS-2B) cell lines was evaluated using com-
mercially available and well-established cytotoxicity assays, AB
and MTT.36–38 Fig. 1 shows the dose dependent changes in cel-
lular viability, at time points from 24 to 72 h, as determined by
the AB (Fig. 1A, C and E) and MTT (Fig. 1B, D and F) assays.
The cell viability assays are based on measurement of a fluo-
rescent marker corresponding to a specific change in the
whole cell population under investigation.39 The AB assay pro-
vides information about the cell viability and proliferation
while the MTT assay has been shown to have contribution
from the mitochondrial activity of the cell.36,40–43 Although
MTT reduction can occur in different cellular regions, upon
reduction of MTT dye to its fluorescent form by electron trans-
fer after 25 min of incubation, around 25–45% of MTT
reduction was shown to be associated with mitochondria by
Bernas et al.44 In the study of Maher et al., MTT assay was
found to be more sensitive than AB to the effect of exposure of
cells to PAMAM dendrimers, which mainly localise in the
mitochondria and cause changes in mitochondrial integrity.45
Therefore, the MTT results can be interpreted in terms of func-
tional changes of the mitochondria.
Even though the AB and MTT assays have different mecha-
nisms for measuring toxic effects of the nanoparticles, in
terms of applied dose, both assays provided comparable
results for all cell lines and the toxicity progressively increased
with increasing dose (from 0.15 to 20 μM) as seen in Fig. 1.
When the AB response of A549, Calu-1 and BEAS-2B cells are
compared, a general trend of increasing toxicity response in
the order Calu-1 > BEAS-2B > A549 is observed (Fig. 1). For all
three cell lines and exposure times, viability in the exposed
cells is observed at around 100% for the lowest concentration
of the PS-NH2, while the percentage approaches zero for
higher concentrations (Fig. 1A, C and D). The half-maximal
concentrations for cellular viability (EC50) were calculated by
using a four parameter sigmoidal fit in SigmaPlot and the
results are shown in Table 1. However, although the trend,
Calu-1 > BEAS-2B > A549, remains the same for three cell lines,
the AB assay does not show a significant difference in EC50
values between 48 and 72 h exposure for BEAS-2B cells (from
2.87 ± 0.41 to 3.20 ± 0.38 μM). When the confidence interval is
calculated, EC50 is calculated to be in the range of
3.28–2.46 μM for 48 h and 3.58–2.82 μM for 72 h.
Notably, whereas the viability as measured by the AB assay
for extended exposure times tends towards 10–0% for the cell
lines, for the MTT assay, the increase in toxicity is observed to
be less systematic for A549 and Calu-1 cells and the minimum
viability, even at 72 h exposure, is observed around ∼50–40%
(Fig. 1B, D and F). This is indicative of sustained mitochon-
drial activity or increase in the number of mitochondria in
cells upon exposure to PS-NH2. In contrast, the viability of the
BEAS-2B continues to reduce with increasing dose and extended
exposure times, tending towards 10–0%, a similar profile to the
AB response (Fig. 1A, C and E). From a pharmacological point
of view, agonists can have partial or full efficacy on a receptor.
While ‘full agonism’ can cause a reduction in viability to 0%,
‘partial agonism’ can cause the loss of viability to saturate at
finite values, even at prolonged exposure times.46 By analogy,
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the MTT response in A549 and Calu-1 can be described as
“partial agonism” as the viability only goes to about 50%,
whereas in BEAS-2Bs, there is almost a full loss of viability.
In recent years, the mechanisms underlying the toxicity of
nanoparticles have been widely studied and various contri-
butions have been identified, such as induction of oxidative
stress upon nanoparticle uptake, cascades of inflammatory
responses, counteracted by natural cell defense mechanisms
(e.g. antioxidants).15,21,22,31,32,34,47,48 In the case of the PS-NH2,
partial agonism determined by the MTT assay shows evidence
of more than one mechanism governing the toxic response.
The partial agonistic MTT response for A549 and Calu-1 cells
can also be attributed to more effective defense mechanisms,
such as more effective antioxidant quenching of ROS in cancer
cell lines compared to non-cancerous cell lines.49 Conversely,
for the BEAS-2B cells, the similar response and systematic
changes (‘full agonistic response’ for all exposure times) deter-
mined by both assays can be related to the prevalence of one
toxic pathway leading to cell death.
Fig. 1 Cytotoxicity of 100 nm amine-modified polystyrene nanoparticles (PS-NH2) after 24 h (A and B), 48 h (C and D) and 72 h (E and F) exposures,
as determined by the Alamar Blue (A, C and E) and MTT (B, D and F) assay, for A549, Calu-1 and BEAS-2B cell lines. The concentration range
between 20 and 0.15 μM is used throughout the study. Data are expressed as % of control mean ± SD of three independent experiments.
Table 1 Calculated EC50 values with standard deviation for A549, Calu-
1 and BEAS-2B cell lines from 24 to 72 h PS-NH2 exposure
Cell lines Viability assays
EC50 values (μM)
24 h 48 h 72 h
A549 AB 6.00 (±1.15) 4.62 (±0.13) 2.50 (±0.5)
MTT 5.20 (±0.59) 3.63 (±0.55) 3.99 (±0.12)
Calu-1 AB 1.96 (±0.33) 0.85 (±0.11) 0.58 (±0.04)
MTT 0.30 (±0.42) 0.47 (±0.03) 0.33 (±0.01)
BEAS-2B AB 4.17 (±0.24) 2.87 (±0.41) 3.20 (±0.38)
MTT 2.00 (±0.06) 1.39 (±0.27) 0.97 (±0.18)
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Morphological changes in cancerous and non-cancerous cells
upon PS-NH2 exposure
Morphological changes also provide valuable information about
the cell viability and overall cell health. In the case of cellular
stress and activation of cell death pathways leading to apoptosis
and necrosis, significant changes occur in the overall cell struc-
ture such as cell shrinkage or swallow, alterations and aberra-
tions in the cell membrane, cell blebbing or budding and for-
mation of stress related granular structures.50–52 In order to
observe morphological effects of the systematic changes on
BEAS-2B cells upon PS-NH2 exposure, CLSM was employed to
visualise exposed cells compared to their corresponding con-
trols from 24 to 72 h (Fig. 2). Extending exposure times from 24
to 72 h, control cells are observed to be affected by nutrient con-
sumption53 and several morphological changes are observed in
the cell membrane and cytoplasm. Cellular stress related lipid
granules were observed after 48 h (indicated by an arrow in
Fig. 2) and the change in the cellular morphology is observed
significantly after 72 h. For PS-NH2 exposed cells, 0.6 μM con-
centrations of PS-NH2 were chosen as a sub-lethal dose (∼EC25
values at 24 h exposure determined by MTT) for the CLSM
study. After 24 h particle exposure, PS-NH2 are observed to be
mainly localised in the perinuclear region. After 72 h, excessive
amounts of PS-NH2 are observed in the cytoplasmic area and
morphological changes become highly visible. For all exposure
times, the formation of stress related lipid granules was
observed to be increased upon particle exposure. Compared to
their controls for each exposure time, significantly higher distor-
tion in the cell structure is observed.
Consistent with the known trafficking of PS nanoparticles,
after 24 h exposure, the particles are observed to be in the peri-
nuclear region which shows the localisation of the nanoparticles
in the endoplasmic reticulum. With the extending exposure
times, although uptake and trafficking of the PS-NH2 continue
and the amount of the particles increase inside the cell, no local-
isation of the particles are observed in the nuclear region.22
Raman microspectroscopic evolution of the spectral markers
of toxicity in cancerous and non-cancerous cell lines
In order to investigate in more detail the systematic changes
within PS-NH2 exposed BEAS-2B cells determined by the MTT
assay and CLSM, Raman spectra were acquired from 20 points
within the cytoplasm of the exposed cells and their corres-
ponding controls. For the Raman study, the ∼EC25 at 24 h
exposure determined by the MTT assay (0.6 μM concentration
of PS-NH2) was chosen as a sublethal dose at which the time
dependent changes in the cell line were observed.
The spectral changes in BEAS-2B, the non-cancerous cell
line, upon PS-NH2 exposure from 24 to 72 h were evaluated by
using PCA. The scatter plots of PCA obtained from comparison
of the cytoplasm of the exposed and unexposed BEAS-2B cells
after 24, 48 and 72 h particle exposure are provided in ESI
Fig. S1.† For all exposure times, exposed cells clearly separated
from their controls according to PC1, with increasing
explained variance with increasing exposure times. In all
cases, control cells are observed to form more compact clus-
ters, which indicate higher variance in particle exposed cells,
as might be expected. The explained variances are calculated
to be 62, 84 and 89% for 24, 48 and 72 h, respectively, which
indicates the significant changes in cell composition upon
PS-NH2 exposure. The loadings of PC1 for control versus
PS-NH2 exposed BEAS-2B cells, from 24 to 72 h, are provided
in Fig. 3. In each loading, negative features (PC < 0) represent
Fig. 2 CLSM images of BEAS-2B cells and BEAS-2B cells exposed to
100 nm aminated polystyrene nanoparticles (indicated by green fluor-
escent) from 24 to 72 hours. ×60 magnification.
Fig. 3 Loadings of the first component of PCA (PC1), each exposure
time is indicated by a colour from 24 h to 72 h as following: blue, red
and black. The positive side of the loadings represents the spectral fea-
tures of the particle exposed cells (0.6 μM of PS-NH2), while the negative
side represents the control cells for each loading. Loadings are offset for
clarity and the dotted line represents the zero ‘0’ point for each loading.
The changing features with extended particle exposure times are indi-
cated by a black dashed area.
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the dominant features of the cytoplasm of control cells and
positive features (PC > 0) represent the features of PS-NH2
exposed cells. The most significant changes in the loadings
are observed in the range between 1000 and 1800 cm−1 and
are indicated by black dashes (band assignments are provided
in Table S1†). When the loadings of PC1 for different exposure
times are compared, significant differences are observed
between 24 and 48 h particle exposure, including inversion of
bands between control and exposed cells (Fig. 3). After 24 h
exposure, protein (1003 cm−1, phenylalanine (Phe); 1033 cm−1,
Phe; 1248 cm−1, amide III of proteins, also attributed to
nucleic acids, guanine (G) or cytosine (NH2); 1339 cm
−1, Phe,
tyrosine (Tyr); 1658 cm−1 amide I (α-helix)54 band of proteins)
and lipid bands (1440 cm−1, lipids)54–56 are observed in the
positive features of the PC1, which indicates an increased
amount of protein and lipids in PS-NH2 exposed compared to
control cells. Although the highest peak observed in the range
of 1600 to 1700 cm−1 is identified at 1658 cm−1, the region can
have many contributions in this region from lipids (CvO and/
or CvC band) and also some residual water (bound of semi-
bound –OH).57,58 The possible contributions in the range and
their assignments are provided in Table S1.† The increased sig-
natures of proteins in particle exposed cells compared to their
corresponding controls can be attributed to the changes in the
protein template and formation of altered protein structures
and also changes in post-translational modifications of the
proteins and problems in protein degradation mechanisms
due to the changes in cell signalling upon nanoparticle
uptake.59–61 Also, it can be attributed to formation of more
Raman active proteins or conformational changes.62 Uptake
and removal mechanism of the nanoparticles also leads to the
formation of lipid based structures such as lysosomes to facili-
tate cellular trafficking of the nanoparticles, which results in
an increase in lipid bands. Moreover, formation of stress
related lipid granules in the cytoplasm observed with CLSM
can contribute to the increase in the lipid band at 1440 cm−1.
After 48 and 72 h exposure, the most prominent bands are
observed in the negative features of loading 1, which represents
a higher amount of the corresponding cellular constituents in
control cells compared to PS-NH2 exposed cells. The lipid and
protein bands are inverted to negative features of the loading 1
which indicates damage and loss of the protein and lipids in
particle exposed cells. The increase of the features in the
loading from 48 to 72 h indicates the progress of the cascade of
events in the cell, resulting in further degradation in protein
and lipid structures due to the toxicity of the particles.
The decrease in lipid composition of the cells after 48 and
72 h exposure can be attributed to the lysosomal aberrations
due to long exposure times. The uptake mechanism of the
PS-NH2 nanoparticles is known to be endocytosis. Briefly, par-
ticles are taken up by endosomes in the first 4 h and carried to
lysosomes within 12 h, which are engulfed by Golgi apparatus
or endoplasmic reticulum after 24 h.22 However, amine groups
located on the surface provide a cationic surface charge to
PS-NH2. Therefore, particles create a proton-sponge effect in
the early endosomes and lysosomes which cause protonation
in lysosomes.15,63–67 Reduction in protein content for these
exposure times can be an indicator of follow up damage in the
exposed cells due to oxidative stress. After 72 h exposure, the
band at 719 cm−1 (membrane phospholipid head,
phosphatidylcholine)54–56 can be used to track damage to
membrane integrity and cellular death phase.
A doublet of peaks at around 785 cm−1 (nucleic acids) and
810 cm−1 (RNA), associated with the changes in the nucleic
acid content in the cytoplasm, has previously been identified
as a potential marker for oxidative stress in the Raman signa-
tures of nanoparticle exposed cells.21 The increasing amount
of the nucleic acid bands in the cytoplasm of the particle
exposed cells compared to control cells can be attributed to
the changes in cytoplasmic RNA and accumulation of non-
coding RNAs in the cytoplasm due to oxidative stress.
However, they are only weakly observed as positive features of
the loading after 24 h particle exposure are not evident at all at
the prolonged exposure times, which shows a lack of RNA
accumulation in the cytoplasm of the exposed BEAS-2B cells
for longer time points.
As seen in Fig. 3, the spectral changes in BEAS-2B cells are
found to be systematic after 24 h particle exposure, which cor-
relates with the full agonistic response determined by AB and
MTT assays and evolving changes in CLSM. Therefore, the sig-
nificant changes in the spectroscopic signatures between 24
and 48 h particle exposure (with an increase in explained var-
iance from 62 to 84%) can be related to initiation of toxic
events (molecular initiation event (MIE)) and the lower
increase in the explained variance (from 84 to 89%) from 48 to
72 h can be attributed to the cascade of following toxic
responses in the cell.
The differences encountered in AB and MTT assays between
BEAS-2B, non-cancerous, and A549 and Calu-1, cancerous, cell
lines were also investigated using Raman microspectroscopy.
The partial agonistic response obtained by the MTT assay for
A549 and Calu-1 cells can be attributed to the differences in
mitochondrial functionality following the nanoparticle uptake.
In order to observe the differences between cell lines in terms
of spectroscopy, 20 point spectra from the cytoplasm of
different individual cells were acquired for each exposed cell
line and their corresponding controls. For the Raman study,
concentrations of 2.5, 1 and 0.6 μM PS-NH2 were chosen as
sub-lethal doses (∼EC25 values at 24 h exposure) to observe
time dependent changes in the cell lines.
The 72 h exposure time was chosen to compare cellular
responses as more obvious changes (‘full agonistic response’
for BEAS-2B, ‘partial agonistic response’ for A549 and Calu-1)
are observed for the MTT assay results at this time point
(Fig. 1). PCA was applied pairwise between controls and par-
ticle exposed cells after 72 h exposure. The scatter plots of the
PCA of the cytoplasm of exposed and control cells for A549
and Calu-1 cells after 72 h are shown in ESI Fig. S2.† The
exposed cells differentiate according to PC1 from their controls
43% and 46% for A549 and Calu-1 cells, respectively. For
BEAS-2Bs, exposed cells largely differentiate from controls
(explained variance 89%, Fig. S1†). Fig. 4 shows the first load-
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ings of PCA for BEAS-2B, A549 and Calu-1 cells, corresponding
to the cytoplasm. When the first loadings are compared,
similar trends in the spectral range from 1000 to 1800 cm−1
for A549 and BEAS-2B cells are observed, which can be attribu-
ted to similarities in the cascade of events for one type of toxic
pathway which can also be attributed to the similarities in the
full agonistic cellular response determined by the AB assay.
The spectral range from 1000 to 1800 cm−1 of the so-called fin-
gerprint region includes many characteristic bands related to
protein and lipid content of the cells. When the chosen range
is considered, for all cell lines, loadings are dominated by
negative features. The bands at 1266 cm−1 (amide III-α helix),
1298 cm−1 (lipids) and 1438 cm−1 (lipids and proteins) are
observed as positive features of the loading for the Calu-1
cells. The band at 1658 cm−1, which can specifically be attribu-
ted to the amide I (α-helix) of proteins,54 is observed as nega-
tive features of the loadings for BEAS-2B and A549 cells,
whereas the peak manifests as a positive feature for the Calu-1
cells, indicating a lower amount of damage in amide I band of
the proteins in the Calu-1 cells compared to the other cell
lines. For A549 cells, the positive features in the range from
1600 to 1700 cm−1 can be attributed to partial aberrations in
protein and lipid band (CvC and/or CvO) characteristics of
this region. The inverted structure of these bands can be
attributed to damage of protein and lipid structures in particle
exposed cells after 72 h. Although the cell lines are different
from each other, the spectral signatures of cell damage leading
to cell death in later stages are found to be similar and cell
damage upon toxicity can be determined using Raman micro-
spectroscopy which can be used to utilize a single step analysis
of cell–nanoparticle interaction for different cell lines.
Although a general trend is observed in the AB responses
and spectral signatures of cell damage for all three cell lines in
the higher wavenumber region of the fingerprint, a signifi-
cantly different trend is observed for the lower wavenumber
region, 785–810 cm−1, which indicates the presence of
different molecular initiating events, as well as the presence of
a secondary toxic pathway leading to cell death upon toxic
nanoparticle exposure.
The prominent peaks at 785 cm−1 (nucleic acid) and
810 cm−1 (RNA), in the loadings corresponding to the cytoplasm
of A549 and Calu-1 cells are indicative of nucleic acid alterations
in the cytoplasm due to oxidative stress, as previously discussed
for A549 cells.21 However, the peaks are absent in the loading of
BEAS-2B cells after 72 h exposure. Although ROS such as hydro-
gen peroxide (H2O2), superoxide anion (O
2•−) and hydroxyl
radicals (HO•) are known to be Raman inactive and are con-
sumed in cells quickly after they are produced,68,69 the 785 and
810 cm−1 bands can be used to track oxidative stress inside the
cells in a completely label free manner.21
The nucleic acid bands in the cytoplasm have been identi-
fied as a signature of formation and accumulation of noncod-
ing RNAs due to oxidative stress upon particle exposure.21 In
order to further explore this process in the cytoplasm of the
different cell lines, the ROS levels of A549, Calu-1 and BEAS-2B
cells were measured by using the carboxy-H2DCFDA dye
(Fig. 5). The concentrations for ROS measurements were kept
the same as the concentrations used for the Raman study for
each line (0.6, 1 and 2.5 μM for BEAS-2B, Calu-1 and A549,
respectively) in order to observe the ROS levels corresponding
to the doublet of peaks. The results show significantly lower
ROS formation in the BEAS-2B cells, which is consistent with
the absence of the double peak in the lower wavenumber
region. For this reason, the formation of ROS can be identified
as a molecular initiating event for the A549 and Calu-1 cell
lines, which leads to cell damage and ultimately cell death.
In order to see earlier effects of the molecular initiating
event for the different cell lines, spectral changes were also
Fig. 5 % of reactive oxygen species (ROS) generation compared to con-
trols for A549, Calu-1 and BEAS-2B cell lines after 1, 2, 3, 4, 6 and 24 h
PS-NH2 exposure. The concentrations used for BEAS-2B, Calu-1 and
A549 are 0.6, 1 and 2.5 μM, respectively.
Fig. 4 First loadings of PCA of cytoplasm of control and 72 hour par-
ticle exposed cells for BEAS-2B, A549 and Calu-1 cell lines, respectively;
loadings are offset for clarity and the dotted line represents the zero ‘0’
point for each loading. The positive side of the loadings (PC > 0) rep-
resents the spectral features of the particle exposed cells, while the
negative side (PC < 0) represents the control cells for each loading. The
areas with changing features between cell lines are indicated by dashed
lines.
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investigated at shorter exposure times (24 and 48 h) and pair-
wise PCA of cytoplasm corresponding to the exposed cells and
their controls was carried out. The scatter plots of PCA of cyto-
plasm of exposed and control cells are provided in ESI Fig. S1
(A and B†) for BEAS-2B and Fig. S3† for A549 and Calu-1 cells
after 24 and 48 h. The explained variance between control and
exposed cells according to PC1 increases to 64 and 59% for
A549 and Calu-1 cells and PS-NH2 exposed BEAS-2Bs differen-
tiate from their controls 84% after 48 h exposure. The increase
in explained variance after 48 h exposure compared to 72 h for
A549 and Calu-1 cells can be attributed to higher stress in the
control cells due to rapid consumption of medium by metabo-
lically active cancer cell lines.70 A representative example of the
morphological changes in control cells after 48 and 72 h
exposure, as seen by white light microscopy, is shown for A549
cells in ESI Fig. S4.† Changes in cell shape, membrane integ-
rity and formation of lipid vesicles, relating to the oxidative
stress, are observed with increasing exposure time. When the
exposure time is reduced to 24 h, A549, Calu-1 and BEAS-2B
cells differentiate from the corresponding controls according
to PC1, explaining ∼50–60% for all cell lines. Fig. 6 shows the
loadings of PC1 corresponding to the cytoplasm of exposed
and control cells after 24, 48 and 72 h for A549 (A) and Calu-1
(B) cells. A549 and Calu-1 cell lines show similar responses in
the lower wavenumber region and the double peak at 785 and
810 cm−1 is prominently observed for all exposure times (Fig. 6
(A and B)). The change in the bands at 785 and 810 cm−1 also
shows similarity in terms of the intensity ratio of the 785/
810 cm−1 bands, which indicates comparable changes in RNA
accumulation for both cell lines (Fig. 6). Conversely, the
double peak, 785 and 810 cm−1, is absent in the loading of
PC1 of the BEAS-2B cell line after 48 h exposure (Fig. 3). When
the exposure time is reduced to 24 h, the double peak has low
intensity, which indicates the production of ROS in low levels
and rapid consumption for the BEAS-2B cell line. The signifi-
cantly higher intensity of 785 and 810 cm−1 bands can be
attributed to higher amounts of accumulated nucleic acids in
the cytoplasm of A549 and Calu-1 cells compared to BEAS-2B
cells, consistent with the higher levels of ROS observed (Fig. 5).
When different cell lines are compared in the higher wave-
number region of the fingerprint, above 1000 cm−1, after 24
and 48 h exposure, similar trends are observed in A549 and
Calu-1 cells, which are mainly an increase or a decrease in
protein and lipid related bands in particle exposed cells com-
pared to their corresponding controls (Fig. 6(A) and (B)).
However, BEAS-2B cells show a significant change between 24
and 48 h (Fig. 3), which can be attributed to a more rapid and
single step mechanism in the cytotoxic response rather than
multiple mechanisms. The rapid toxic response can be related
to the full agonistic mechanism of the BEAS-2B cells (Fig. 1)
determined by the AB and MTT assays, which is also consist-
ent with the less effective defence mechanisms of non-cancer-
ous cell lines.71
As seen in Fig. 6(A) for A549 cells, after 48 h exposure, the
loading of PC1 is dominated by negative features above
1000 cm−1. The bands at 1266 cm−1 (amide III/α-helix),
1298 cm−1 (lipids), 1438 cm−1 (lipids, proteins) and 1658 cm−1
(amide I (α-helix)) are observed in the negative features of the
loadings, which is consistent with damage to protein and lipid
content of the exposed cells. The damage and loss in lipid
composition of the cell can be attributed to protonation in
lysosomes, lipidosis and ultimately lysosomal rupture as well
as higher ROS levels in the cell upon PS-NH2 exposure. The
oxidative stress also causes alterations and damage to proteins
in the cytosolic region of the exposed cells. When the exposure
time is reduced to 24 h, A549 cells show changes in the same
features as the loadings of 48 h, with less damage to protein
and lipid structures. For the Calu-1 cell line, similar to the
A549 cells, the loading of PC1 is dominated by negative fea-
tures above 1000 cm−1 (Fig. 6(B)). The bands at 1266 cm−1
(amide III/α-helix), 1298 cm−1 (lipids) and 1438 cm−1 (lipids,
proteins) are observed in the negative features of the loading.
However, the range from 1600 to 1700 cm−1 of the Calu-1 cells
shows significant differences compared to that of A549 cells.
This region, as a broad band formed by multiple sub-bands,
can be related to different molecular vibrations such as C–C,
CvO54 and indicates the presence of lipid and proteins
(Table S1†). Although the band at 1658 cm−1 (amide I (α-helix))
Fig. 6 Comparison of the first loadings of PCA of cytoplasm of control and particle exposed A549 (A) and Calu-1 (B) cell lines after 24, 48 and
72 hour particle exposure; loadings are offset for clarity and the dotted line represents the zero ‘0’ point for each loading. The positive side of the
loadings represents the spectral features of the particle exposed cells, while the negative side represents the control cells for each loading. The
changing features between cell lines are indicated with dashed lines.
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can be identified as a negative feature in the loading, the
general changes in the protein content of exposed cells are
observed as positive features after 24 and 48 h exposure, which
indicates a higher amount of proteins as well as more Raman
active proteins in the PS-NH2 exposed cells compared to the
corresponding controls. The later effect on protein structures
compared to lipid content can be explained by a cascade of
events in the cell upon toxic particle exposure. The onset of
lipidosis, change in pH gradient and ROS formation can
impact on proteins at later stages, compared to the lipid based
changes in the earlier stages. Moreover, the change in the
spectral markers of proteins and lipids in Calu-1 cells with
increasing exposure time is not observed to be as significant
as A549 cells which can be attributed to a slower cytotoxic
response.
Conversely, for the BEAS-2B cells, the formation of the cel-
lular damage cannot be attributed to ROS due to low levels of
measured ROS and the absence of the double peak at 785 and
810 cm−1, even though similar signatures of cell damage
response are observed in the range above 1000 cm−1 with A549
and Calu-1 cells. Although ROS is one of the mechanisms for
cellular damage, other toxic pathways can be identified for cell
death. pH gradient of the cells can have a significant contri-
bution to damage in biochemical composition of the cells as
well as effecting the working mechanism of the cellular com-
partments.72 The levels of the protonation in acidic organelles
such as endosomes and lysosomes were measured using the
Lysosensor dye. Lysosensor is known to be a pH dependent
dye which quantifies the lysosomal content. As seen in Fig. 7,
BEAS-2B cells show a continuous protonation in lysosomes
over a 24 h period. In contrast, A549 and Calu-1 cells show
fluctuations in protonation. Changes and fluctuations in the
amount of protonated lysosomes can be explained by three
different events occurring in the cell upon PS-NH2 exposure.
First, the proton pump effect can be initiated by PS-NH2
uptake into cells and formation of endosomes. After 3 to 4 h
exposure, fusion of endosomes in lysosomes occurs and lyso-
somal protonation can initiate the second source of protona-
tion, while the third can be related to lysosomal rupture. The
fluctuations in protonation also show these additional proto-
nation stages such as lysosomal rupture in A549 and Calu-1
cells compared to BEAS-2B cells. The lysosomal rupture has a
significant effect on ROS formation, which ultimately affects
the RNA in the cytoplasm and results in accumulation of the
noncoding RNAs. Although there are fluctuations in the levels
for A549 (A) and Calu-1 (B) cells, the lysosomal protonation
can contribute to cellular toxicity, in concert with ROS formation.
On the other hand, the main reason for PS-NH2 toxicity to
BEAS-2B cells can be a continuous proton pump effect which
affects the internal pH and ultimately pH gradient in the cyto-
solic region. Continuous changes in the internal pH can show
a significant effect on the working mechanism of the mito-
chondria which needs a proton gradient for energy production
and full functionality.73 The effect of PS-NH2 on the mitochon-
dria of BEAS-2B cells can also be seen from the MTT response
and full agonistic feature of PS-NH2 for the BEAS-2B cell line.
Overall, the cellular toxicity of PS-NH2 for A549 and Calu-1
cells can be associated with two mechanisms, whereas
BEAS-2B shows only one main mechanism. Briefly, after
PS-NH2 are taken up by A549 and Calu-1 cells, they give rise to
the proton pump effect in lysosomes, which elicits a partial
MTT response and changes mitochondrial activity as one
mechanism. The ROS formation due to subsequent lysosomal
rupture can be identified as the main mechanism which leads
to cell damage and death, resulting in the full agonistic AB
response. Conversely, BEAS-2B cells retain the lysosomal integ-
Fig. 7 Changes in lysosomal protonation measured by Lysosensor activity in A549 (A), Calu-1 (B) and BEAS-2B (C) cell lines.
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rity and elicit a full agonistic response in MTT. The proton
pump effect and the changes in mitochondrial function leads
to cell death. A schematic representation of the different path-
ways for different cell lines can be seen in Fig. 8.
Previous studies have shown the higher susceptibility of the
lysosomal-mediated cell death in cancer cell lines compared to
the normal cells.74 The relatively larger size of the lysosomes
in the cancer cells are shown to make the lysosomal structure
more fragile which makes the lysosomal alterations more
common in cancerous cells.75 In the study by LeGendre et al.,
anticancer effects of the (−)-oleocanthal, a phenolic compound
in olive oil, has been demonstrated on the cancerous and non-
cancerous cell lines and it has been found to selectively induce
cell death in cancer cell lines due to fragility of the lysosomes
and changes in lysosomal membrane permeabilization.75
Therefore, the differences between cancer and non-cancerous
cell lines observed by Raman microspectroscopy which can be
attributed to lysosomal rupture resulting in cell death as a
second mechanism for cancerous cell lines, A549 and Calu-1,
can also be attributed to lysosomal alterations due to larger
size and fragility of the lysosomes. The CLSM images of the
PS-NH2 exposed cells also show a different distribution of the
nanoparticles inside the cytoplasmic area after 24 h for A549
and Calu-1 cells compared to BEAS-2B cells (ESI Fig. S5†). For
the A549 (A) and Calu-1 (B), PS-NH2 are observed to be more
spread in the cytoplasm, whereas the particles are observed to
localise in the perinuclear region for BEAS-2B (C) cells which
indicates evidence of common lysosomal rupture in the can-
cerous cell lines.
In this study, Raman microspectroscopy is shown to
provide information in a rapid way with high sensitivity regard-
ing overall cellular health, lysosomal and mitochondrial
changes, changes in the biochemical composition of the cell,
oxidative stress, from early stage particle exposure to cell
death, as a function of time, in a range of cell lines. Raman
microspectroscopy can be applied to different areas, from
in vitro toxicology to medicinal chemistry,21,76–80 as a high
content screening technique, due to the multifaceted infor-
mation contained in the fingerprint region and the technique
can potentially replace the cellular and biochemical assays
which require the use of multiple assays with multiple labels.
The use of labels for the evaluation of cellular processes as
well as localisation studies has been widely studied in
different areas.15,81,82 However, the labels are known to be
specific to one cellular event, whereas a complex series of
events can take place inside the cell as a response to a single
stimulus. The specificity of the labels brings the requirement
of the use of multiple assays which is inefficient in terms of
cost and time. Notably, when the complexity of cells, tissues
and higher animal models are considered, the amount of
assays and analysis required to complete the picture of inter-
action mechanisms and efficacies and responses significantly
retards the whole process for pharmaceutical and medical
applications. As it is label free, Raman microspectroscopy uses
the intrinsic properties of the biochemical constituents of the
cells and spectral markers of subcellular events occurring
inside the cell and allows the detection of the changes without
targeting a specific molecule or event. For example, the cyto-
toxicity assays used in this study are based on measurement of
the resorufin (pink and highly fluorescent) and formazan
(purple) products inside the cell which are produced as a
result of resazurin and MTT reduction by AB and MTT assays,
respectively.40,41 Therefore, although conventional cytotoxicity
assays such as AB and MTT provide valuable indications of the
response of a cell population, they are based on the measure-
ment of a specific marker and do not provide any information
on the mechanism of action or response pathways. Differing
responses are commonly obtained from different assays, and
the collective responses of multiple assays are not readily inter-
pretable. As a high content screening technique, Raman
microspectroscopy, can elucidate the mechanism of action
and different pathways leading to toxicity. The particle depen-
dent (ROS) and cellular dependent (damage in protein and
lipid structures, which gives information about cellular viabi-
lity) spectral markers can be applied to predict nanoparticle
toxicity. The consistencies in the spectral markers of the par-
ticle and cellular dependent events can be converted into more
quantitative measurements with the analysis of spectral
marker intensities versus dose and time. Moreover, further
refinements of the data analysis and quantification protocols
can be achieved by using more sophisticated data mining
methods such as PC-LDA (Principal Component-Linear
Discriminant Analysis) and Partial Least Squares Regression
analysis (PLSR) to achieve improved differentiation and
quantification.
Conclusion
Although conventional cytotoxicity assays, AB and MTT,
provide valuable information about the toxicity of PS-NH2, the
techniques have been shown to be limited by the nature of the
measurement methodology. The individual technique relies
Fig. 8 Schematic representation of different cell death pathways for
A549, Calu-1 and BEAS-2B cell lines. The pathway for the BEAS-2B cell
line is indicated by red arrows, while that for A549 and Calu-1 is rep-
resented by black arrows.
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on the colorimetric changes on a specific marker. The varying
results obtained from different assessments, which reflects the
measurement of a different specific marker, can show a high
impact on the evaluation of the nanoparticle toxicity and the
reliability of the results. However, Raman microspectroscopy
can provide deeper insights into toxic pathways by using
intrinsic properties of biological molecules which are pro-
duced and consumed during cellular events. Upon exposure to
a toxicant, spectral markers of the molecular initiating events
and the subsequent cascade of events can be determined
using Raman microspectroscopy. The spectral markers of tox-
icity obtained by Raman microspectroscopy can be observed in
multiple cell lines and allow the prediction of the mechanism
of action of the nanomaterial.
This study has further demonstrated the different cellular
responses and mechanisms leading to cell death between can-
cerous and non-cancerous cell lines can be differentiated by
using the spectral markers of the cellular toxic events. The
doublet peak, 785–810 cm−1, is identified as a signature of
ROS related changes in the biochemical composition of the
cell upon a toxicant exposure and the changes upon activation
of the cell death mechanism has been identified with the
region over 1000 cm−1 with the changes in protein and lipid
structures.
The proof of concept study has demonstrated the consist-
ency of the Raman spectroscopic signatures at a subcellular
level, as a result of cell exposure to nanoscale toxicants, for the
example of the commercially available PS-NH2. It demonstrates
that the signatures of the initial responses to oxidative stress
are consistent in different cell lines, and furthermore that the
subsequent cellular responses can be interpreted in terms of
characteristic signatures, including those of the cellular
defence mechanisms, which are potentially quantifiable as a
function of dose and/or exposure time. The confocal spectro-
scopic technique therefore provides a holistic view of the
initiation stage of the toxicity as well as the cellular response
in a high content, label free readout.
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